We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Genomic spectra of biliary tract cancer.
- Authors
Shibata, Tatsuhiro; Nakamura, Hiromi; Hosoda, Fumie; Elzawahry, Asmaa; Shirota, Tomoki; Totoki, Yasushi; Kato, Mamoru; Kosuge, Tomoo; Hiraoka, Nobuyoshi; Shimada, Kazuaki; Okusaka, Takuji; Hama, Natsuko; Ojima, Hidenori; Arai, Yasuhito; Miyagawa, Shinichi; Ohashi, Shoko; Urushidate, Tomoko
- Abstract
The incidence of biliary tract cancer (BTC), including intrahepatic (ICC) and extrahepatic (ECC) cholangiocarcinoma and gallbladder cancer, has increased globally; however, no effective targeted molecular therapies have been approved at the present time. Here we molecularly characterized 260 BTCs and uncovered spectra of genomic alterations that included new potential therapeutic targets. Gradient spectra of mutational signatures with a higher burden of the APOBEC-associated mutation signature were observed in gallbladder cancer and ECC. Thirty-two significantly altered genes, including ELF3, were identified, and nearly 40% of cases harbored targetable genetic alterations. Gene fusions involving FGFR2 and PRKACA or PRKACB preferentially occurred in ICC and ECC, respectively, and the subtype-associated prevalence of actionable growth factor-mediated signals was noteworthy. The subgroup with the poorest prognosis had significant enrichment of hypermutated tumors and a characteristic elevation in the expression of immune checkpoint molecules. Accordingly, immune-modulating therapies might also be potentially promising options for these patients.
- Subjects
BILIARY tract cancer; MEDICAL genomics; MITOGEN-activated protein kinases; ACTIN; MULTIPLE correspondence analysis (Statistics)
- Publication
Nature Genetics, 2015, Vol 47, Issue 9, p1003
- ISSN
1061-4036
- Publication type
Article
- DOI
10.1038/ng.3375